MedPath

Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism

Not Applicable
Conditions
Gonarthrosis
Interventions
Procedure: femoral nerve block
Registration Number
NCT02411097
Lead Sponsor
General Hospital of Ningxia Medical University
Brief Summary

To investigate whether preemptive analgesic of femoral nerve block could prevent deep venous thromboembolism due to inhibiting the excessive release of neutrophil elastase and inflammatory cytokines.

Detailed Description

Femoral nerve block is an effective analgesic mode in patients after total knee arthroplasty. In recent studies, there has been shown that a large amount of neutrophil elastase release from neutrophils could induce the development of deep venous thromboembolism and femoral nerve block may reduce the incidence of the development of deep venous thromboembolism. In addition, inflammatory cytokines including interleukin-1(IL-1), IL-6, IL-8 and tumor necrosis factor(TNF) were associated with deep venous thromboembolism. Thus, the investigators hypothesised that preemptive analgesic of femoral nerve block could prevent deep venous thromboembolism due to inhibiting the excessive release of neutrophil elastase and inflammatory cytokines.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • adult patients scheduled for total knee arthroplasty under general anesthesia
Exclusion Criteria
  • ASA physical status Ⅳ-Ⅴ,
  • psychiatric illness,
  • chronic opioid consumption,
  • patient refusal,
  • coagulopathy,
  • peripheral neurological injury,
  • local anesthesia drug allergy,
  • preoperative existing deep venous thromboembolism.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
femoral nerve blockfemoral nerve blockfemoral nerve block will be administered before or after the surgery
Primary Outcome Measures
NameTimeMethod
Serum concentration of inflammatory cytokinechange from baseline at 30min, 60min, 90min after using tourniquet and 12h, 24h,48h after operation
Secondary Outcome Measures
NameTimeMethod
Concentration of related inflammatory factors of deep venous thromboembolismchange from baseline at 30min, 60min, 90min after using tourniquet and 12h, 24h,48h after operation

inflammatory factors include IL-1, IL-6, IL-8 and TNF,detecting the concentrations by enzyme-linked immunosorbent assay (ELISA).

Trial Locations

Locations (1)

General Hospital of Ningxia Medical University

🇨🇳

Yinchuan, Ningxia, China

© Copyright 2025. All Rights Reserved by MedPath